The Scotts Miracle-Gro Company SMG
Composite 46/100; the shares have moved about 44% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 23/100 — a strong mark against it.
Income ranks 95/100 — a strong point in its favour. Valuation ranks 66/100 — a moderate point in its favour.
Growth ranks 23/100 — a strong mark against it. Quality ranks 38/100 — a moderate mark against it. Momentum ranks 42/100 — a slight mark against it.
What the company does The Scotts Miracle-Gro Company manufactures and markets lawn, garden, and hydroponic products under brands such as Scotts, Miracle-Gro, and Turf Builder. Its portfolio includes fertilizers, seeds, pest control solutions, and indoor gardening systems.
Key financials SMG reports gross margins of 32.5%, operating margins of 27.7%, and net margins of 3.2%. Revenue grew 5.0% and EPS grew 8.5%. ROE is -47.6%, ROA is 8.8%, and ROCE is 20.4%. The company has a dividend yield of 3.9% with a payout ratio of 94.3%.
Stock health The stock shows mixed signals: 3-month momentum is 10.67%, 6-month is 11.05%, and 12-month is 5.20%. It is 9.33% below its 52-week high, with an RSI(14) of 51.60. SideraVIA scores it 52.9 overall, with strengths in Income (71.6) and Valuation (56.8).
Price vs fair value SMG trades at a PREMIUM of 10.90% to our fair-value estimate of 60.86 and a discount of 12.72% to the analyst 12-month target of 77.00. - Q3 2026 earnings topped estimates, highlighting strong sales growth (Zacks). - Recent earnings call highlights emphasized cost management and growth (MarketBeat, GuruFocus.com, Moby). - Analysts (6.0) maintain a bullish 12-month target of 77.00, suggesting upside potential.
Looking forward Forward P/E is 16.84 (PEG 0.92), below the trailing P/E of 19.92. EV/EBITDA stands at 12.84. Debt metrics include a net debt/EBITDA of 3.91 and interest coverage of 3.72. The company’s hydroponic segment and organic product lines may drive future growth.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.